Condition: COVID-19 · Sponsor: Emory University
This study aims to investigate if receiving doses of arginine (a protein in the body) will improve mitochondria function in children with COVID-19. The study will be performed at the Children's Healthcare of Atlanta, Arthur M. Blank Hospital. Patients will be randomized to receive one of three doses of arginine three times a day for five days or at discharge whichever comes first.
This description comes directly from the study's public registry record.
Claudia R. Morris, MD · 404 727-5500 · claudia.r.morris@emory.edu
Dunia Hatabah, MD · 470-6626706 · dunia.hatabah@emory.edu
Always discuss trial participation with your own doctor first.
| Children's Healthcare of Atlanta (CHOA), Arthur M. Blank | Atlanta, Georgia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05855330